Weakly immunogenic CRISPR therapies
Crossref DOI link: https://doi.org/10.1038/s41551-019-0463-7
Published Online: 2019-10-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wilson, Eric A. http://orcid.org/0000-0002-4104-1445
Anderson, Karen S.
Text and Data Mining valid from 2019-10-07
Version of Record valid from 2019-10-07
Article History
First Online: 7 October 2019
Competing interests
: K.S.A. is noted as an inventor on a patent application regarding Cas9 immunity.